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Highly heterogeneous disease, in terms
of severity, progression, exercise
tolerance and nature of symptoms.
Background:
Tobacco smoke
and other noxious
particles or gases
Difficult to treat and to manage!
Transient and apparently stochastic 
periods of increased symptoms.
ACUTE EXACERBATIONS (AECOPD)
COPD
Chronic and 
persistent airflow
limitation
Persistent
respiratory
symptoms
➢ Dyspnea
➢ Cough
➢ Fatigue
➢ Sputum production
➢ Small airway damage
➢ Alveolar damage
Globally is the 3rd leading cause of death
WHO The top 10 causes of death. Fact sheet. Updated May 2018
Are typically treated with a combination of antibiotics and steroids in
a non-specific manner, without understanding its aethiology.
Research challenges:
What is the role of lung microbiota in the onset of AECOPD?
MICROBIOTA
INFLAMATION CLINICAL 
DATA
Hypothesis: DYSBIOSIS of the commensal airway/lung 
microbiota PRECEDES THE ONSET OF AECOPD
What is the advantage of combining multi-type data (microbial,
inflammatory and clinical) to predict AECOPD?
Is the pathoadaptation of the resident microbiota an essential trigger
of AECOPD?
Research method and techniques:
Collection of
Longitudinal 
samples and 
Clinical Data from
16 AECOPD
Saliva sample 
collection
DNA extraction and 
suppernatant collection
16s rRNA sequencing
ELISA
Bacterial cultures
and species isolation
Whole genome
sequencing of each
specie
Bioinformatic
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Mild
FEV1≥80% I-Mild
FEV1≥80% 
II-Moderate
50%≤FEV1<79%
IV-Very severe
FEV1<30%
III-Severe
30%≤FEV1<49%
≥2 or ≥1 leading to hospital admission 
0-1 not leading to hospital admission 
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Results:
Results:
Patients with COPD have an enrichment of Proteobacteria
phylum, specifically of Neisseria, Haemophilus,
Campylobacter and Aggregatibacter genera.
Streptococcus
Veilonella
Prevotella
Neisseria
Haemophillus
Campylobacter
Aggregatibacter
Leptotrichia
Microbiota
diversity and 
composition 
is different 
among 
patients and 
healthy 
controls
Healthy COPD
Results:
Patients with poorer respiratory health have less
diverse airway microbiotas!
It was also possible to stratify patients according to several clinical parameters:
Severe COPD 
MICROBIOME
Very severe
COPD 
MICROBIOME

No           Yes
Long term oxygen therapy (>16h)
No           Yes
Hospital admission due to 
exacerbation
Lower Risk Higher Risk
Number of exacerbations
Severe Very Severe
(30-49)             (<30)
FEV1pp
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